Concepedia

Scott T. Aaronson

ST

Statistics

Publications

9

Citations

270

H-Index

9

Active since

1986

Affiliations

Sheppard Pratt Health System(Current)

Washington University in St. Louis

Duke-NUS Medical School

Newcastle University

King's College London

Scott T. Aaronson is an author at Sheppard Pratt Health System specializing in antidepressant therapy, psychiatry, and pharmacotherapy.

ORCID

Publications per year

1986–2024

9

Publications

9

Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania

Mauricio Tohen, Eduard Vieta, Guy M. Goodwin et al. · The Journal of Clinical Psychiatry · 2008 · 88 citations

, , +9

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

Teresa A. Pigott, Apurva Prakash, Lesley M. Arnold et al. · Current Medical Research and Opinion · 2007 · 59 citations

, , +16

Selective impairment of nutrient absorption from intestines with chronic venous hypertension.

I. James Sarfeh, Scott T. Aaronson, D Lombino et al. · PubMed · 1986 · 27 citations

, , +16

Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study

Sagar V. Parikh, Scott T. Aaronson, Sanjay J. Mathew et al. · Neuropsychopharmacology · 2023 · 24 citations · Full text

, , +17

Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance

Jeffrey R. Strawn, Scott T. Aaronson, Ahmed Z. Elmaadawi et al. · Journal of Child and Adolescent Psychopharmacology · 2020 · 20 citations · Full text

, , +13

1–5 of 9